Are actual tumor measurements or categorical tumor response status better at predicting overall survival in cancer clinical trials?
- Citation:
- J Clin Oncol vol 26 (15s) abstr 6520
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 2723
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. D. Mandrekar S. L. Hillman M. E. Campbell B. Hobbs R. M. Goldberg A. Adjei D. J. Sargent
- Networks:
- Study
- NCCTG-N9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: